In BREATH and PAGES, genotypes were determined by using Taqman-based allelic discrimination assays on an ABI 7,700 sequence detection system (Applied Biosystems, Foster City, Calif)4 (link),27 (link) In followMAGICS, samples were genotyped using Illumina Sentrix HumanHap300 BeadChip array (Illumina, Inc.)15 (link) In both GALA II and SAGE, samples were genotyped using the Axiom® LAT1 array (Affymetrix Inc.), and quality control (QC) procedures were performed as described previously.28 (link),29 (link) In PACMAN and ESTATe, samples were genotyped using the Illumina Infinium CoreExome-24 BeadChip (Illumina, Inc.).30 In PASS, genotyping was performed using the Illumina Omni Express 8v1 array (Illumina, Inc.). QC procedures and imputation are described elsewhere.22 (link) In SCSGES, genotyping was conducted using Kompetitive Allele Specific PCR (KASP) genotyping platform (LGC, Inc). QC was performed based on the quality of clustering.23 (link) In the SLOVENIA study, genotyping of 336 samples was performed with the Illumina Global Screening Array-24 v1.0 BeadChip (Illumina). QC procedures and imputation described elsewhere.30